Biologics Symposium: All you need to know 1. Anti-TNFs and anti-integrins: Journey so far 2. JAK inhibition: tofacitinib and beyond 3. Ustekinumab: will it be the game changer? 4. Positioning biologics and small molecules: the current perspective 5. Audience Interaction 6. Launch of IBD-ENC Biologics Registry